Fundz

Nuclein, Llc reported raising $9.39 Million in an initial SEC Form D filing

PRIVATESep 10, 2019

Amount Raised

$9.39 Million

$9.39 Million sold, per SEC Form D (first sale Sep 10, 2019)

Round Type

Venture

AustinBiotechnology

Who to call at Nuclein, and when

A new round usually means Nuclein is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nuclein raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuclein, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuclein. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuclein

Location

8305 Cross Park Dr

Austin, Texas, United States

About

Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR System was designed to offer low-cost, sensitive and specific results, with robust multiplexing across various sample types, and requires less than one minute of hands-on time. Nuclein has raised approximately $50 million to date, led by private equity firm Trinity Investors. In 2023, Nuclein merged with Minute Molecular Diagnostics, Inc., a Northwestern University spin-out that initially developed the DASH System.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuclein raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMark H., VP, Operations hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nuclein's next move

See what Strategic adds

Nuclein raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.